|
1
|
Rose-Inman H and Kuehl D: Acute leukemia.
Emerg Med Clin North Am. 32:579–596. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Terwilliger T and Abdul-Hay M: Acute
lymphoblastic leukemia: A comprehensive review and 2017 update.
Blood Cancer J. 7(e577)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Daver NG, Iqbal S, Renard C, Chan RJ,
Hasegawa K, Hu H, Tse P, Yan J, Zoratti MJ, Xie F and Ramsingh G:
Treatment outcomes for newly diagnosed, treatment-naïve
TP53-mutated acute myeloid leukemia: A systematic review and
meta-analysis. J Hematol Oncol. 16(19)2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Malard F and Mohty M: Acute lymphoblastic
leukaemia. Lancet. 395:1146–1162. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shallis RM, Wang R, Davidoff A, Ma X and
Zeidan AM: Epidemiology of acute myeloid leukemia: Recent progress
and enduring challenges. Blood Rev. 36:70–87. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pulte D, Gondos A and Brenner H:
Improvement in survival in younger patients with acute
lymphoblastic leukemia from the 1980s to the early 21st century.
Blood. 113:1408–1411. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pulte D, Jansen L, Gondos A, Katalinic A,
Barnes B, Ressing M, Holleczek B, Eberle A and Brenner H: GEKID
Cancer Survival Working Group. Survival of adults with acute
lymphoblastic leukemia in Germany and the United States. PLoS One.
9(e85554)2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hunger SP, Lu X, Devidas M, Camitta BM,
Gaynon PS, Winick NJ, Reaman GH and Carroll WL: Improved survival
for children and adolescents with acute lymphoblastic leukemia
between 1990 and 2005: A report from the children's oncology group.
J Clin Oncol. 30:1663–1669. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Suguna E, Farhana R, Kanimozhi E, Kumar
PS, Kumaramanickavel G and Kumar CS: Acute myeloid leukemia:
Diagnosis and management based on current molecular genetics
approach. Cardiovasc Hematol Disord Drug Targets. 18:199–207.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bennett JM, Catovsky D, Daniel MT,
Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposals for the
classification of the acute leukaemias. French-American-British
(FAB) co-operative group. Br J Haematol. 33:451–458.
1976.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Arber DA, Orazi A, Hasserjian R, Thiele J,
Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M and Vardiman JW:
The 2016 revision to the World Health Organization classification
of myeloid neoplasms and acute leukemia. Blood. 127:2391–2405.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Blackburn LM, Bender S and Brown S: Acute
leukemia: Diagnosis and treatment. Semin Oncol Nurs.
35(150950)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sekar MD, Raj M and Manivannan P: Role of
morphology in the diagnosis of acute leukemias: Systematic review.
Indian J Med Paediatr Oncol. 44:464–473. 2023.
|
|
15
|
Ladines-Castro W, Barragán-Ibañez G,
Luna-Pérez MA, Santoyo-Sánchez A, Collazo-Jaloma J, Mendoza-García
E and Ramos-Peñafiel CO: Morphology of leukaemias. Rev Méd Hosp Gen
Méx. 79:107–113. 2016.
|
|
16
|
Haznedaroğlu İC, Kuzu I and İlhan O: WHO
2016 definition of chronic myeloid leukemia and tyrosine kinase
inhibitors. Turk J Haematol. 37:42–47. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shi M, Qin Y, Chen S, Wei W, Meng S, Chen
X, Li J, Li Y, Chen R, Su J, et al: Characteristics and risk
factors for readmission in HIV-infected patients with Talaromyces
marneffei infection. PLoS Negl Trop Dis.
17(e0011622)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu CA, Zhang Q, Ruan GT, Shen LY, Xie HL,
Liu T, Tang M, Zhang X, Yang M, Hu CL, et al: Novel diagnostic and
prognostic tools for lung cancer cachexia: Based on nutritional and
inflammatory status. Front Oncol. 12(890745)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ma TT, Lin XJ, Cheng WY, Xue Q, Wang SY,
Liu FJ, Yan H, Zhu YM and Shen Y: Development and validation of a
prognostic model for adult patients with acute myeloid leukaemia.
EBioMedicine. 62(103126)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Koller CA, Kantarjian HM, Feldman EJ,
O'Brien S, Rios MB, Estey E and Keating M: A phase I-II trial of
escalating doses of mitoxantrone with fixed doses of cytarabine
plus fludarabine as salvage therapy for patients with acute
leukemia and the blastic phase of chronic myelogenous leukemia.
Cancer. 86:2246–2251. 1999.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lo-Coco F, Avvisati G, Vignetti M, Thiede
C, Orlando SM, Iacobelli S, Ferrara F, Fazi P, Cicconi L, Di Bona
E, et al: Retinoic acid and arsenic trioxide for acute
promyelocytic leukemia. N Engl J Med. 369:111–121. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Rego EM, Kim HT, Ruiz-Argüelles GJ,
Undurraga MS, Uriarte Mdel R, Jacomo RH, Gutiérrez-Aguirre H, Melo
RA, Bittencourt R, Pasquini R, et al: Improving acute promyelocytic
leukemia (APL) outcome in developing countries through networking,
results of the international consortium on APL. Blood.
121:1935–1943. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Dayama A, Dass J, Seth T, Mahapatra M,
Mishra PC and Saxena R: Clinico-hematological profile and outcome
of acute promyelocytic leukemia patients at a tertiary care center
in North India. Indian J Cancer. 52:309–312. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hoelzer D, Bassan R, Dombret H, Fielding
A, Ribera JM and Buske C: ESMO Guidelines Committee. Acute
lymphoblastic leukaemia in adult patients: ESMO clinical practice
guidelines for diagnosis, treatment and follow-up. Ann Oncol. 27
(Suppl 5):v69–v82. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Pui CH, Robison LL and Look AT: Acute
lymphoblastic leukaemia. Lancet. 371:1030–1043. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Schumacher HR, Alvares CJ, Blough RI and
Mazzella F: Acute leukemia. Clin Lab Med. 22:153–192.
2002.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Cornell RF and Palmer J: Adult acute
leukemia. Dis Mon. 58:219–238. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cripe LD: Adult acute leukemia. Curr Probl
Cancer. 21:1–64. 1997.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Meenaghan T, Dowling M and Kelly M: Acute
leukaemia: Making sense of a complex blood cancer. Br J Nurs.
21:76. 78–83. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gralnick HR, Galton DAG, Catovsky D,
Sultan C and Bennett JM: Classification of acute leukemia. Ann
Intern Med. 87:740–753. 1977.
|
|
31
|
Weiss MJ and Orkin SH: Transcription
factor GATA-1 permits survival and maturation of erythroid
precursors by preventing apoptosis. Proc Natl Acad Sci USA.
92:9623–9627. 1995.PubMed/NCBI View Article : Google Scholar
|
|
32
|
McDevitt MA, Fujiwara Y, Shivdasani RA and
Orkin SH: An upstream, DNase I hypersensitive region of the
hematopoietic-expressed transcription factor GATA-1 gene confers
developmental specificity in transgenic mice. Proc Natl Acad Sci
USA. 94:7976–7981. 1997.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ayala RM, Martínez-López J, Albízua E,
Diez A and Gilsanz F: Clinical significance of Gata-1, Gata-2,
EKLF, asnd c-MPL expression in acute myeloid leukemia. Am J
Hematol. 84:79–86. 2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Perkins AC, Sharpe AH and Orkin SH: Lethal
beta-thalassaemia in mice lacking the erythroid CACCC-transcription
factor EKLF. Nature. 375:318–322. 1995.PubMed/NCBI View
Article : Google Scholar
|
|
35
|
Creutzig U, Zimmermann M, Ritter J, Henze
G, Graf N, Löffler H and Schellong G: Definition of a standard-risk
group in children with AML. Br J Haematol. 104:630–639.
1999.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Redaelli A, Lee JM, Stephens JM and Pashos
CL: Epidemiology and clinical burden of acute myeloid leukemia.
Expert Rev Anticancer Ther. 3:695–710. 2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ganzel C and Rowe JM: Prognostic factors
in adult acute leukemia. Hematol Oncol Clin North Am. 25:1163–1187.
2011.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Arellano M, Bernal-Mizrachi L, Pan L,
Tighiouart M, Souza L, Guo X, McLemore M, Lima L, Sunay S, Heffner
LT, et al: Prognostic significance of leukopenia at the time of
diagnosis in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk.
11:427–432. 2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sasaki K, Ravandi F, Kadia TM, DiNardo CD,
Short NJ, Borthakur G, Jabbour E and Kantarjian HM: De novo acute
myeloid leukemia: A population-based study of outcome in the United
States based on the surveillance, epidemiology, and end results
(SEER) database, 1980 to 2017. Cancer. 127:2049–2061.
2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hu J, Liu YF, Wu CF, Xu F, Shen ZX, Zhu
YM, Li JM, Tang W, Zhao WL, Wu W, et al: Long-term efficacy and
safety of all-trans retinoic acid/arsenic trioxide-based therapy in
newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci
USA. 106:3342–3347. 2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Bassan R and Hoelzer D: Modern therapy of
acute lymphoblastic leukemia. J Clin Oncol. 29:532–543.
2011.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Baccarani M, Corbelli G, Amadori S,
Drenthe-Schonk A, Willemze R, Meloni G, Cardozo PL, Haanen C,
Mandelli F and Tura S: Adolescent and adult acute lymphoblastic
leukemia: Prognostic features and outcome of therapy. A study of
293 patients. Blood. 60:677–684. 1982.PubMed/NCBI
|
|
43
|
Ng SM, Lin HP, Ariffin WA, Zainab AK, Lam
SK and Chan LL: Age, sex, haemoglobin level, and white cell count
at diagnosis are important prognostic factors in children with
acute lymphoblastic leukemia treated with BFM-type protocol. J Trop
Pediatr. 46:338–343. 2000.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Settin A, Al Haggar M, Al Dosoky T, Al Baz
R, Abdelrazik N, Fouda M, Aref S and Al-Tonbary Y: Prognostic
cytogenetic markers in childhood acute lymphoblastic leukemia.
Indian J Pediatr. 74:255–263. 2007.PubMed/NCBI View Article : Google Scholar
|
